Breaking Finance News

Infosys Ltd ADR (NYSE:INFY) has been upgraded to Hold in a statement by Zacks Investment Research today.

Yesterday Infosys Ltd ADR (NYSE:INFY) traded -1.78% lower at $16.05. The company’s 50-day moving average is $16.13 and its 200-day moving average is $17.75. The last stock close price is down -10.08% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 3,066,289 shares of the stock were exchanged, down from an average trading volume of 4,961,940

Zacks Investment Research has upgraded Infosys Ltd ADR (NYSE:INFY) to Hold in a report released on 09/21/2016.

Previously on Friday September 09, 2016, Wedbush reported about Infosys Ltd ADR (NYSE:INFY) raised the target price from $0.00 to $18.00. At the time, this indicated a possible upside of 0.12%.

See Chart Below

Infosys Ltd ADR (NYSE:INFY)

Infosys Ltd ADR has a price-earnings ratio of 17.54 with a one year low of $15.64 and a one year high of $20.47 INFY’s total market value is currently $0.

Brief Synopsis On Infosys Ltd ADR (NYSE:INFY)

Infosys Limited is engaged in consulting, technology, outsourcing and next-generation services. The Company, along with its subsidiaries, provides business information technology services comprising application development and maintenance, independent validation, infrastructure management, engineering services comprising product engineering and life cycle solutions and business process management; consulting and systems integration services comprising consulting, enterprise solutions, systems integration and advanced technologies; products, business platforms and solutions to accelerate intellectual property-led innovation, including Finacle, its banking solution, and offerings in the areas of Analytics, Cloud and Digital Transformation. Its segments are Financial Services and Insurance (FSI), Manufacturing and Hi-tech (MFG & Hi-TECH), Energy & utilities, Communication and Services (ECS), Retail, Consumer packaged goods and Logistics (RCL), and Life Sciences and Healthcare (LSH).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *